VRXValeant Pharmaceuticals International, Inc. (NYSE)
2 members of Congress disclosed 6 transactions in VRX between Mar 11, 2014 and Apr 22, 2016.
6
Transactions
5 buys · 1 sells
2
Members
~$48K
Est. volume
0D / 2R
Party split
distinct members
Who traded it
| Member | Trades | Buys / Sells | Est. volume |
|---|---|---|---|
| Susan M. CollinsR-ME | 4 | 3 / 1 | ~$32K |
| Michael T. McCaulR-TX | 2 | 2 / 0 | ~$16K |
Transactions
6| Member | Type | Amount | Traded | Disclosed | Source |
|---|---|---|---|---|---|
| Buyspouse | ~$8K $1,001–$15,000 | Apr 22, 2016 | May 25, 2016 33d | filing unverified | |
| Buyspouse | ~$8K $1,001–$15,000 | Feb 19, 2016 | Mar 18, 2016 28d | filing unverified | |
| Buyspouse | ~$8K $1,001–$15,000 | Mar 11, 2014 | Jul 20, 2015 496d · late | filing | |
| Buyspouse | ~$8K $1,001–$15,000 | Mar 11, 2014 | May 13, 2015 428d · late | filing | |
| Sellspouse | ~$8K $1,001–$15,000 | May 7, 2014 | May 16, 2014 9d | filing | |
| Buyspouse | ~$8K $1,001–$15,000 | Mar 11, 2014 | Mar 19, 2014 8d | filing |
Disclosures are filed up to 45 days after a trade, so this is a record rather than a signal. Amounts are bracket midpoints. Symbols are recorded as they existed on the trade date and mapped forward where a company was renamed.